Skip to main content

Table 1 Participant characteristics

From: Resilience level and its association with maladaptive coping behaviours in the COVID-19 pandemic: a global survey of the general populations

 

n (%)

Age (years)

 18–29

1152 (66.7)

 30–39

266 (15.4)

 40–49

165 (9.5)

  ≥ 50

145 (8.4)

Sex

 Male

582 (33.8)

 Female

1140 (66.2)

Years of Education

 0–9

73 (4.2)

 10–12

262 (14.9)

  > 12

1420 (80.9)

Residence

 Urban

1121 (63.8)

 Rural

454 (25.8)

 Others

182 (10.4)

Living status

 Alone

169 (9.6)

 Family members

1411 (80.3)

 Other people or none of the above

177 (10.1)

Private financial situation in the past six months

 Increased

305 (17.3)

 Decreased

417 (23.7)

 Remains the same

926 (52.6)

 Do not know

110 (6.2)

Weight change over the past six months

 Increased

713 (40.9)

 Decreased

242 (13.9)

 Remained the same

710 (40.8)

 Do not know

77 (4.4)

Past medical history

 Cardiovascular disease

45 (2.6)

 Diabetes

43 (2.5)

 Immunodeficiencya

54 (3.2)

 Respiratory diseases

136 (7.9)

 Liver diseases

30 (1.8)

 Kidney diseases

31 (1.8)

 Cancer in the past five years

29 (1.7)

 Sickle cell diseases

27 (1.6)

 Obesity (Body mass index ≥ 30 kg/m2)

192 (11.2)

 Mental health issuesb

151 (8.6)

 Tested positive for COVID-19

171 (16)

Past medical historyc

 0

1216 (69)

 1

392 (22.2)

  ≥ 2

154 (8.7)

  1. Missing responses were excluded in individual characteristics
  2. aIncluding those who took medication that suppresses the immune system
  3. bMental health issues include mania/bipolar disorders, psychotic disorders (including schizophrenia), post-traumatic stress disorder, eating disorder, obsessive compulsive disorder, substance abuse and addiction disorder, attention disorder (Attention Deficit Disorder [ADD] or Attention Deficit Hyperactivity Disorder [ADHD]), somatoform disorder, personality disorder, autism spectrum disorder, cognitive disorder/dementia
  4. cPast medical history includes: cardiovascular disease, diabetes, immunodeficiency, respiratory diseases, liver diseases, kidney diseases, cancer in the past five years, sickle cell diseases, obesity (BMI ≥ 30 kg/m2), mental health issues; and COVID-19